Business ❯ Healthcare

Drug Development

Clinical Trials Market Competition Biosimilars Market Performance Collaboration Pharmaceuticals Generic Drugs Immunotherapy Incretin Medications Cancer Treatment

Karyopharm Raises $30 Million in RA Capital Private Placement

The structure ties potential extra funding to Phase 3 selinexor results.

Zydus, Aurobindo Report Q3 Profit Growth as U.S. Sales Climb and Labour-Code Charges Weigh

AbbVie Beats Q4 and Raises 2026 Outlook as Shares Fall on Aesthetics, Oncology Concerns

Merck Beats Q4 Forecasts as 2026 Guidance Trails Estimates on Patent Losses

Novo’s Wegovy Pill Posts Quick Uptake, Boosting Shares as Oral GLP‑1 Battle Nears

Crinetics Wins FDA Approval for Oral Acromegaly Drug Palsonify as JMP Lifts Price Target

BMO Raises AbbVie Target to $240 After Rinvoq Generic Dispute Is Resolved

Novo Nordisk Freezes Hiring as Layoffs Loom in GLP-1 Retrenchment

Dr. Reddy’s and Alvotech Partner to Develop Global Keytruda Biosimilar

Novo Nordisk Faces Investor Turmoil as Wegovy Sales and Market Share Decline

SpringWorks Shares Surge on Reported Acquisition Talks with Merck KGaA

Eli Lilly Lowers 2024 Revenue Forecast as Weight-Loss Drug Sales Lag

Biogen Boosts Profit Forecast as Alzheimer's Drug Leqembi Gains Traction

Johnson & Johnson Raises Revenue Forecast Despite Legal Costs Impact

Eli Lilly Invests $1.8 Billion to Expand Drug Production in Ireland